Lan T. Tran
Chief Administrative Officer at EMMAUS LIFE SCIENCES, INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Yutaka Niihara | M | 65 |
Emmaus Medical, Inc.
Emmaus Medical, Inc. BiotechnologyHealth Technology Emmaus Medical, Inc. engages in the discovery, development and commercialization of treatments and therapies for rare diseases. Its current business is the late-stage development presently in Phase III clinical trials with the FDA of the amino acid L-glutamine as a prescription drug for the treatment of Sickle Cell Disease. The company was founded on December 20, 2000 and is headquartered in Torrance, CA.
Emmaus Medical Europe Ltd.
Newfield Nutrition Corp.
| 17 years |
Willis Lee | M | 64 |
Emmaus Medical, Inc.
Emmaus Medical, Inc. BiotechnologyHealth Technology Emmaus Medical, Inc. engages in the discovery, development and commercialization of treatments and therapies for rare diseases. Its current business is the late-stage development presently in Phase III clinical trials with the FDA of the amino acid L-glutamine as a prescription drug for the treatment of Sickle Cell Disease. The company was founded on December 20, 2000 and is headquartered in Torrance, CA.
Newfield Nutrition Corp.
| 14 years |
Ian Zwicker | M | 77 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | 9 years |
Henry McKinnell | M | 81 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA.
Emmaus Medical, Inc.
Emmaus Medical, Inc. BiotechnologyHealth Technology Emmaus Medical, Inc. engages in the discovery, development and commercialization of treatments and therapies for rare diseases. Its current business is the late-stage development presently in Phase III clinical trials with the FDA of the amino acid L-glutamine as a prescription drug for the treatment of Sickle Cell Disease. The company was founded on December 20, 2000 and is headquartered in Torrance, CA. | 14 years |
George Sekulich | M | 59 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | 10 years |
Wei Peu Zen | M | 71 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | 6 years |
Peter Ludlum | M | 68 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA.
Newfield Nutrition Corp.
| 6 years |
Yasushi Nagasaki | M | 57 |
Newfield Nutrition Corp.
| 13 years |
Dale E. Short | M | - | 6 years | |
Charles Stark | M | 68 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | 11 years |
Mark Diamond | M | - | - | |
Seah LIm | M | 66 | 2 years | |
Albert Carnesale | M | 87 |
University of California, Los Angeles
| 27 years |
Chandrashekhar J. Joshi | M | - |
University of California, Los Angeles
| 26 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Furmanski Chris | M | - |
University of California, Los Angeles
| 6 years |
Masaharu Osato | M | 70 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | 7 years |
Robert Dickey | M | 68 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | 4 years |
Justin M. Sobaje | M | - |
University of California, Los Angeles
| 9 years |
Yu Hin Wang | M | 38 |
University of California, Los Angeles
| 8 years |
Jane Pine Wood | F | 62 | 2 years | |
Jesse Draper | F | - |
University of California, Los Angeles
| 4 years |
Akiko Miyashita | F | 68 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | 1 years |
Edward Fan | M | - |
University of California, Los Angeles
| 5 years |
Tracey Doi | F | 63 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | 4 years |
Wing Cheung Hwang | M | 48 |
University of California, Los Angeles
| 6 years |
Anicia Mendez | F | - |
University of California, Los Angeles
| 8 years |
Joseph C. Sherwood | M | 69 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | 1 years |
Douglas W. Wilmore | M | 85 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | - |
Scott A. Henry | M | - |
University of California, Los Angeles
| 2 years |
Mayuran Sriskandarajah | M | 43 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | 1 years |
Brian Lowery | M | - |
University of California, Los Angeles
| 5 years |
Matt MacKenzie | M | - |
University of California, Los Angeles
| 7 years |
Timothy J. Brasel | M | 65 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | 2 years |
Phillip M. Satow | M | 81 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | 1 years |
Maurice J. DeWald | M | 84 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | 3 years |
Michael M. Kagawa | M | - |
University of California, Los Angeles
| 18 years |
Alfred Osborne | M | 79 |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | 1 years |
Elemer Piros | M | - |
University of California, Los Angeles
| 8 years |
John Soden | M | 59 |
University of California, Los Angeles
| 2 years |
Brian T. Brugman | M | - |
University of California, Los Angeles
| 5 years |
Jennifer Wu | F | - |
University of California, Los Angeles
| 4 years |
Geoffrey Garrett | M | 65 |
University of California, Los Angeles
| 4 years |
Melissa K. Rowe | M | - |
University of California, Los Angeles
| 3 years |
Sean Foster | M | - |
University of California, Los Angeles
| 2 years |
Daphne M. Tam | F | - |
University of California, Los Angeles
| 3 years |
Jesslyne Widjaja | F | 39 |
University of California, Los Angeles
| 4 years |
Eytan Elbaz | M | - |
University of California, Los Angeles
| 3 years |
Shirley Lee | F | - |
University of California, Los Angeles
| 4 years |
Stephen W. Lyford | M | 51 |
University of California, Los Angeles
| 2 years |
Jeetil J. Patel | M | 51 |
University of California, Los Angeles
| 4 years |
Chris Thornberg | M | - |
University of California, Los Angeles
| 6 years |
Janice S. Y. Wang | F | 40 |
University of California, Los Angeles
| 4 years |
Dane Elden Lewis | M | - |
University of California, Los Angeles
| 2 years |
Shierley Widjaja | F | - |
University of California, Los Angeles
| 4 years |
Melanie Jocson | F | - |
University of California, Los Angeles
| 4 years |
Ravi Malik | M | 63 |
University of California, Los Angeles
| 2 years |
Nora Ku | M | - |
University of California, Los Angeles
| 11 years |
Marcela Meirelles | M | - |
University of California, Los Angeles
| 5 years |
Charles E. Young | M | 92 |
University of California, Los Angeles
| - |
Edmondo Robinson | M | - |
University of California, Los Angeles
| 6 years |
Justin Gibson | M | - |
University of California, Los Angeles
| 4 years |
Natalie Wolfsen | F | 54 |
University of California, Los Angeles
| 2 years |
Pik Wah Yeung | M | 55 |
University of California, Los Angeles
| 4 years |
Caswell Caroline | F | - |
University of California, Los Angeles
| 4 years |
Avi Padhye | M | - |
University of California, Los Angeles
| 3 years |
Tenny Febyana Halim | F | 50 |
University of California, Los Angeles
| 4 years |
Mark Heller | M | - |
University of California, Los Angeles
| 2 years |
Ben D. Orlanski | M | - |
University of California, Los Angeles
| 3 years |
Jackie Liu | F | - |
University of California, Los Angeles
| 4 years |
Alex Manzo | M | - |
University of California, Los Angeles
| 4 years |
Chris McDonald | M | - |
University of California, Los Angeles
| 2 years |
Kenneth Leslie Powell | M | - |
University of California, Los Angeles
| 4 years |
Gino Nucci | M | - |
University of California, Los Angeles
| 2 years |
John W. Langley | M | - |
University of California, Los Angeles
| 2 years |
Augustin Araya | M | - |
University of California, Los Angeles
| 4 years |
Andy Hargreaves | M | - |
University of California, Los Angeles
| 4 years |
Dennis D. Lamont | M | - |
University of California, Los Angeles
| 3 years |
Aaron Kessler | M | - |
University of California, Los Angeles
| 4 years |
Greg Hermanski | M | - |
University of California, Los Angeles
| 4 years |
Marcelo Choi | M | - |
University of California, Los Angeles
| 5 years |
John F. Schnieders | M | 52 |
University of California, Los Angeles
| 4 years |
Loran F. Graham | M | - |
University of California, Los Angeles
| 4 years |
Noelle Tydlaska | F | - |
University of California, Los Angeles
| 4 years |
Larry W. Edelman | M | - |
University of California, Los Angeles
| 12 years |
Daniel Ezer | M | 44 |
University of California, Los Angeles
| 2 years |
Leanne Karns | F | - |
University of California, Los Angeles
| 2 years |
Kamran Moghtaderi | M | - |
University of California, Los Angeles
| 4 years |
Raymond Barrios | M | - |
University of California, Los Angeles
| 4 years |
Ron Hirson | M | - |
University of California, Los Angeles
| 4 years |
Jason Taney Young | M | 45 |
University of California, Los Angeles
| 4 years |
Alya H. Hidayatallah | F | 48 |
University of California, Los Angeles
| 4 years |
Bruce D. Seder | M | - |
University of California, Los Angeles
| 4 years |
William Perry Faust | M | - |
University of California, Los Angeles
| 3 years |
Michael Isaac Marzouk | M | - |
University of California, Los Angeles
| 2 years |
Daniel Holmes | M | - |
University of California, Los Angeles
| 2 years |
Andre Kovensky | M | 55 |
University of California, Los Angeles
| 2 years |
David Schumacher | M | - |
University of California, Los Angeles
| 2 years |
Steven Charles DeLuca | M | 60 |
University of California, Los Angeles
| 2 years |
Joseph Sooren Simonian | M | - |
University of California, Los Angeles
| 5 years |
Matt Alan Sonnen | M | - |
University of California, Los Angeles
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
United Kingdom | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Lan T. Tran
- Personal Network